Home Cart 0 Sign in  
X

[ CAS No. 156-38-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 156-38-7
Chemical Structure| 156-38-7
Chemical Structure| 156-38-7
Structure of 156-38-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 156-38-7 ]

Related Doc. of [ 156-38-7 ]

Alternatived Products of [ 156-38-7 ]

Product Details of [ 156-38-7 ]

CAS No. :156-38-7 MDL No. :MFCD00004347
Formula : C8H8O3 Boiling Point : -
Linear Structure Formula :- InChI Key :XQXPVVBIMDBYFF-UHFFFAOYSA-N
M.W : 152.15 Pubchem ID :127
Synonyms :
4-HPAA;NSC 27460;NSC 25066;para-Hydroxyphenylacetic Acid;p-Hydroxyphenylacetic Acid;para-HPAA;p-HPAA
Chemical Name :4-Hydroxyphenylacetic Acid

Calculated chemistry of [ 156-38-7 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 40.01
TPSA : 57.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.7 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.88
Log Po/w (XLOGP3) : 0.75
Log Po/w (WLOGP) : 1.02
Log Po/w (MLOGP) : 1.05
Log Po/w (SILICOS-IT) : 1.06
Consensus Log Po/w : 0.95

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.53
Solubility : 4.52 mg/ml ; 0.0297 mol/l
Class : Very soluble
Log S (Ali) : -1.54
Solubility : 4.41 mg/ml ; 0.029 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.58
Solubility : 3.97 mg/ml ; 0.0261 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 156-38-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 156-38-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 156-38-7 ]
  • Downstream synthetic route of [ 156-38-7 ]

[ 156-38-7 ] Synthesis Path-Upstream   1~38

  • 1
  • [ 156-38-7 ]
  • [ 10338-51-9 ]
Reference: [1] Beilstein Journal of Organic Chemistry, 2016, vol. 12, p. 524 - 530
[2] Patent: CN107880085, 2018, A,
  • 2
  • [ 156-38-7 ]
  • [ 531-95-3 ]
Reference: [1] Patent: US2015/57456, 2015, A1,
  • 3
  • [ 156-38-7 ]
  • [ 1698-53-9 ]
  • [ 1698-60-8 ]
Reference: [1] Patent: US4454318, 1984, A,
  • 4
  • [ 156-38-7 ]
  • [ 4693-91-8 ]
Reference: [1] Patent: CN106467499, 2017, A,
  • 5
  • [ 156-38-7 ]
  • [ 108-46-3 ]
  • [ 17720-60-4 ]
YieldReaction ConditionsOperation in experiment
87% With boron trifluoride diethyl etherate In toluene at 100 - 108℃; for 1.5 h; Inert atmosphere Step 1: Reaction to produce l-(2,4-Dihydroxyphenyl)-2-(4-hydroxyphenyl)ethanone [00165] Resorcinol (1,3-dihydroxybenzene) (62.000 g, 563.1 mmol, 1.0 equiv.) and 4- Hydroxyphenylacetic acid (94.237 g, 619.4 mmol, 1.1 equiv.) were added to a 3 neck 2 L round bottomed flask fitted with a paddle, a pressure equalizing addition funnel and a thermometer and a heating mantle. Toluene (350 mL) was added to the flask to give a suspension. The reaction purged with nitrogen and the addition funnel filled with Boron trifluoride etherate (198.201 ml, 1578.0 mmol, 2.8 equiv.) via canula. The reaction was stirred at 150 rpm and boron trifluoride etherate was added in portions of 3-4 mL and the reaction heated. During addition the internal temperature rose to 100 °C. The reaction went through various changes in color from yellow to dark red. After complete addition of boron trifluoride etherate the addition funnel was removed and replaced with a condenser. The reaction was stirred for 1.5 h at an internal temperature of 108 °C. A sample was taken and HPLC analysis indicated the reaction was complete. The reaction was cooled and stirring stopped to give a biphasic solution. A 12 percent aqueous solution of sodium acetate (41 g, 336 mL) was slowly added to the reaction with stirring. The reaction was stirred for 16 hours. A precipitate formed overnight and was collected in a sintered glass funnel. The solid was dried on a vacuum oven for 16 h to give the product as a white powder (119.67 g, 87.0 percent).
87% With boron trifluoride diethyl etherate In toluene at 100 - 108℃; for 1.5 h; Inert atmosphere [00195] Resorcinol (1,3-dihydroxybenzene) (62.000 g, 563.1 mmol, 1.0 equiv.) and 4- Hydroxyphenylacetic acid (94.237 g, 619.4 mmol, 1.1 equiv.) were added to a 3 neck 2 L round bottomed flask fitted with a paddle, a pressure equalizing addition funnel and a thermometer and a heating mantle. Toluene (350 mL) was added to the flask to give a suspension. The reaction purged with nitrogen and the addition funnel filled with Boron trifluoride etherate (198.20 1 ml, 1578.0 mmol, 2.8 equiv.) via canula. The reaction was stirred at 150 rpm and boron trifluoride etherate was added in portions of 3-4 mL and the reaction heated. During addition the internal temperature rose to 100 °C. The reaction went through various changes in color from yellow to dark red. After complete addition of boron trifluoride etherate the addition funnel was removed and replaced with a condenser. The reaction was stirred for 1.5 h at an internal temperature of 108 °C. A sample was taken and HPLC analysis indicated the reaction was complete. The reaction was cooled and stirring stopped to give a biphasic solution. A 12 percent aqueous solution of sodium acetate (41 g, 336 mL) was slowly added to the reaction with stirring. The reaction was stirred for 16 hours. A precipitate formed overnight and was collected in a sintered glass funnel. The solid was dried on a vacuum oven for 16 h to give the product as a white powder (119.67 g,87.0 percent).
87% With boron trifluoride diethyl etherate In toluene at 100 - 108℃; Inert atmosphere Step 1
Reaction to produce l-(2,4-Dihydroxyphenyl)-2-(4-hydroxyphenyl)ethanone_:Resorcinol (1,3-dihydroxybenzene) (62.000 g, 563.1 mmol, 1.0 equiv.) and 4- Hydroxyphenyl acetic acid (94.237 619.4 mmol, 1.1 equiv.) were added to a 3 neck 2 L round bottomed flask fitted with a paddle, a pressure equalizing addition funnel and a thermometer and a heating mantle. Toluene (350 mL) was added to the flask to give a suspension. The reaction purged with nitrogen and the addition funnel filled with Boron trifluoride etherate (198.201 ml, 1578.0 mmol, 2.8 equiv.) via canula. The reaction was stirred at 150 rpm and boron trifluoride etherate was added in portions of 3-4 mL and the reaction heated. During addition the internal temperature rose to 100 °C. The reaction went through various changes in color from yellow to dark red. After complete addition of boron trifluoride etherate the addition funnel was removed and replaced with a condenser. The reaction was stirred for 1.5 h at an internal temperature of 108 °C. A sample was taken and HPLC analysis indicated the reaction was complete. The reaction was cooled and stirring stopped to give a biphasic solution. A 12 percent aqueous solution of sodium acetate (41 g, 336 mL) was slowly added to the reaction with stirring. The reaction was stirred for 16 hours. A precipitate formed overnight and was collected in a sintered glass funnel. The solid was dried on a vacuum oven for 16 h to give the product as a white powder (119.67 g, 87.0 percent).
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1991, # 12, p. 3005 - 3008
[2] Journal of Organic Chemistry, 2000, vol. 65, # 8, p. 2305 - 2308
[3] Journal of Agricultural and Food Chemistry, 1994, vol. 42, # 9, p. 1869 - 1871
[4] Tetrahedron Letters, 2006, vol. 47, # 47, p. 8375 - 8378
[5] Patent: WO2013/90921, 2013, A1, . Location in patent: Paragraph 00165
[6] Patent: WO2014/203129, 2014, A1, . Location in patent: Paragraph 00195
[7] Patent: WO2014/203132, 2014, A1, . Location in patent: Paragraph 00105; 00106
[8] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 11, p. 3703 - 3710
[9] Patent: EP1167364, 2002, A1, . Location in patent: Page 13
[10] Chemical and Pharmaceutical Bulletin, 2009, vol. 57, # 4, p. 346 - 360
[11] Tetrahedron Letters, 2012, vol. 53, # 49, p. 6697 - 6700,4
[12] Tetrahedron Letters, 2012, vol. 53, # 49, p. 6697 - 6700
[13] Journal of Medicinal Chemistry, 1997, vol. 40, # 14, p. 2117 - 2122
[14] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 13, p. 4360 - 4366
[15] Bulletin de la Societe Chimique de France, 1951, p. 82
[16] Patent: US6670346, 2003, B1, . Location in patent: Page column 31; 34
[17] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 2, p. 677 - 681
[18] Journal of Agricultural and Food Chemistry, 2010, vol. 58, # 18, p. 10027 - 10032
[19] Chemical and Pharmaceutical Bulletin, 2012, vol. 60, # 4, p. 513 - 520
[20] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 17, p. 5523 - 5526
[21] Patent: US2015/250802, 2015, A1, . Location in patent: Paragraph 0228
[22] Patent: EP3178480, 2017, A1, . Location in patent: Paragraph 0142
  • 6
  • [ 156-38-7 ]
  • [ 108-46-3 ]
  • [ 17720-60-4 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: at 50 - 60℃;
Stage #2: With water In diethyl ether at 0 - 20℃;
EXAMPLE 62: Trihydroxybenzoin
Resorcinol (100 g, 0.91 mol) and 4-hydroxyphenylacetic acid (138.4 g, 0.91 mol) were dissolved into BF3Et2O (346 ml, 2.73 mol) under N2.
The mixture was stirred and heated at 50-60°C.
After complete reaction, the mixture was cooled to room temperature and poured into a large volume of iced water.
The crude product was filtered off and dried to yield trihydroxybenzoin (70 percent).
mp 211°C.
1H-NMR (Acetone d6): 4.12 (s, 2H), 6.78 (d, 2H), 6.91 (d, 1H), 7.13 (d, 2H), 7.54-7.6 (m, 2H), 8.21 (s, 1H), 8.35 (s, 1H), 8.70 (s, 1H).
Reference: [1] Patent: EP1647549, 2006, A1, . Location in patent: Page/Page column 23
  • 7
  • [ 156-38-7 ]
  • [ 108-46-3 ]
  • [ 17720-60-4 ]
Reference: [1] Synthetic Communications, 2000, vol. 30, # 3, p. 469 - 484
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 2000, vol. 4, p. 567 - 570
  • 8
  • [ 156-38-7 ]
  • [ 85888-81-9 ]
  • [ 55453-87-7 ]
YieldReaction ConditionsOperation in experiment
79.3%
Stage #1: With potassium hydroxide In methanol at 20℃; for 1 h;
Stage #2: Reflux
Stage #3: at 80℃; for 2 h;
Reaction flask was added p-hydroxyphenyl acetic acid (150mmol) 22.67g, potassium hydroxide (200mmol) 11.22g, 90ml of methanol, stirred for 1 hour at room temperature, was added 2- (chloromethyl) benzoic acid (100mmol) 17.06g, heated at reflux The reaction, after the reaction was monitored by TLC, the solvent was distilled off under reduced pressure, 200ml of dichloromethane was added to dissolve, washed with water, dried, concentrated, Eaton reagent was added 7.5percent (mass concentration) 200ml, was heated to 80 deg.] C, stirred for 2 hours, the reaction was completed after addition of saturated sodium carbonate solution, filtration, and recrystallized from ethanol to give Isoxepac (79.3mmol) 21.27g, yield 79.3percent, HPLC purity of 99.9percent.
Reference: [1] Patent: CN105693685, 2016, A, . Location in patent: Paragraph 0050; 0051
  • 9
  • [ 156-38-7 ]
  • [ 55453-87-7 ]
Reference: [1] Patent: WO2011/128911, 2011, A2,
  • 10
  • [ 335200-33-4 ]
  • [ 156-38-7 ]
  • [ 18699-02-0 ]
  • [ 335200-30-1 ]
Reference: [1] Chemical Communications, 2001, # 1, p. 19 - 20
  • 11
  • [ 106664-49-7 ]
  • [ 156-38-7 ]
  • [ 18699-02-0 ]
Reference: [1] Chemical Communications, 2001, # 1, p. 19 - 20
  • 12
  • [ 335200-29-8 ]
  • [ 156-38-7 ]
  • [ 18699-02-0 ]
  • [ 335200-30-1 ]
Reference: [1] Chemical Communications, 2001, # 1, p. 19 - 20
  • 13
  • [ 156-38-7 ]
  • [ 501-94-0 ]
YieldReaction ConditionsOperation in experiment
87%
Stage #1: With sulfuric acid In ethanol for 3 h; Reflux; Inert atmosphere
Stage #2: With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 25℃; for 12 h; Inert atmosphere
Step 1: The formation of 4-(2-hydroxyethyl)phenol. This compoundwas prepared following a literature procedure.54 To a solution of 2-(4-hydroxyphenyl)acetic acid (760 mg, 5 mmol) in ethanol (20 mL) wasadded sulfuric acid (27 μL, 0.5 mmol), and the resulting mixture washeated at reflux for 3 h. After completion monitored by TLC, the solventwas removed under reduced pressure, and the crude product was dissolvedin anhydrous THF (20 mL), followed by the addition of LiAlH4(228 mg, 6 mmol) slowly at 0 °C, and the resulting mixture was allowedto warm to RT for 12 h. After completion monitored by TLC, the solutionwas cooled to 0 °C, and quenched by Na2SO4·10H2O solid and filteredthrough Celite®. The solvent was removed under reduced pressureand the residue was diluted with H2O (20 mL) and extracted with ethylacetate (3×20 mL). The combined organic layers were dried overMgSO4 and concentrated in vacuo. The crude product was purified byflash chromatography (hexane/ethyl acetate 5:1→2:1) to give theproduct as an off-white solid (600 mg, 87percent). Rf (hexane/ethyl acetate2:1): 0.30; 1H NMR (400 MHz, CDCl3): δ 7.10 (2H, dd, J=2.0, 6.4 Hz),6.78 (2H, dd, J=2.0, 6.4 Hz), 4.83 (1H, br.s), 3.83 (2H, dd, J=6.4,15.0 Hz), 2.80 (2H, t, J=6.4 Hz); 13C NMR (100 MHz, CDCl3): δ 154.4,130.6, 130.3, 115.6, 64.0, 38.4. The spectroscopic data matched thatreported in the literature.54
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 20, p. 3260 - 3263
[2] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2006, vol. 45, # 4, p. 1063 - 1066
[3] Journal of the American Chemical Society, 2001, vol. 123, # 35, p. 8618 - 8619
[4] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 22, p. 5852 - 5869
[5] Tetrahedron Letters, 2000, vol. 41, # 33, p. 6415 - 6418
[6] Chemical Communications (Cambridge, United Kingdom), 2012, vol. 48, # 85, p. 10514 - 10516,3
[7] Helvetica Chimica Acta, 1973, vol. 56, p. 2460 - 2479
[8] Journal of the Chemical Society, 1963, p. 2937 - 2943
[9] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 14, p. 3115 - 3120
[10] Journal of Medicinal Chemistry, 1995, vol. 38, # 12, p. 2130 - 2137
[11] Phytochemistry (Elsevier), 1990, vol. 29, # 5, p. 1653 - 1659
[12] Chemistry - A European Journal, 2016, vol. 22, # 9, p. 3009 - 3018
[13] Organic Letters, 2016, vol. 18, # 24, p. 6344 - 6347
[14] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 2, p. 131 - 134
  • 14
  • [ 156-38-7 ]
  • [ 501-94-0 ]
  • [ 7339-87-9 ]
Reference: [1] Chemical Communications (Cambridge, United Kingdom), 2012, vol. 48, # 85, p. 10514 - 10516,3
  • 15
  • [ 156-38-7 ]
  • [ 52798-01-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 21, p. 5488 - 5492
  • 16
  • [ 156-38-7 ]
  • [ 61439-59-6 ]
Reference: [1] Carbohydrate Research, 2006, vol. 341, # 15, p. 2469 - 2477
[2] Journal of Organic Chemistry, 2016, vol. 81, # 4, p. 1367 - 1377
[3] Patent: CN107880085, 2018, A,
[4] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 22, p. 5852 - 5869
  • 17
  • [ 156-38-7 ]
  • [ 17194-82-0 ]
Reference: [1] Chemische Berichte, 1889, vol. 22, p. 2138
  • 18
  • [ 156-38-7 ]
  • [ 17194-82-0 ]
  • [ 29121-26-4 ]
  • [ 24744-58-9 ]
  • [ 38692-80-7 ]
Reference: [1] Helvetica Chimica Acta, 1984, vol. 67, # 6, p. 1484 - 1492
  • 19
  • [ 14191-95-8 ]
  • [ 156-38-7 ]
  • [ 17194-82-0 ]
Reference: [1] Tetrahedron, 1993, vol. 49, # 44, p. 10099 - 10102
  • 20
  • [ 103-82-2 ]
  • [ 156-38-7 ]
  • [ 621-37-4 ]
  • [ 614-75-5 ]
Reference: [1] Tetrahedron Letters, 1983, vol. 24, # 44, p. 4847 - 4850
[2] Tetrahedron Letters, 1983, vol. 24, # 44, p. 4847 - 4850
[3] Bulletin of the Chemical Society of Japan, 1989, vol. 62, # 1, p. 148 - 152
  • 21
  • [ 103-82-2 ]
  • [ 156-38-7 ]
  • [ 621-37-4 ]
  • [ 451-13-8 ]
  • [ 64700-73-8 ]
  • [ 614-75-5 ]
Reference: [1] Agricultural and Biological Chemistry, 1987, vol. 51, # 3, p. 947 - 948
  • 22
  • [ 87-41-2 ]
  • [ 156-38-7 ]
  • [ 55453-89-9 ]
YieldReaction ConditionsOperation in experiment
72.3%
Stage #1: With sodium methylate In methanol; N,N-dimethyl-formamide at 100 - 130℃;
Stage #2: With water In methanol; N,N-dimethyl-formamide at 100℃;
Stage #3: With hydrogenchloride In methanol; water; N,N-dimethyl-formamide at 10℃;
Example 1 Synthesis of the Intermediate 4-(2-Carboxybenzyloxy)Phenylacetic Acid (Olo-IM1) A solution of 4-hydroxyphenylacetic acid (90.0 g, 0.58 mol; assay >98percent) and phthalide (85.07 g, 0.63 mol) in DMF (323 g) was heated to an internal temperature of 130° C. The pressure was reduced to 800 mbar and sodium methoxide (224.6 g, 1.25 mol, assay: 30percent methanolic solution) was added slowly to the mixture maintaining the internal temperature above 100° C. During the addition methanol was distilled off, and after the addition the distillation was continued under normal pressure until the internal temperature increased to 130° C. again (260 g distillate). After stirring at this temperature for 6.5 h, phthalide (8.5 g, 0.06 mol) was added and the mixture was stirred overnight (16 h). Afterwards the mixture was cooled to 100° C. and hydrolyzed with water (1040 g). After cooling to <10° C., the pH of the mixture was adjusted to pH 1 with hydrochloric acid (163.5 g, 1.43 mol; assay: 32percent). The product was filtered off, washed with water (700 g) and dried under vacuum for 15 hours at 60° C. to give crude 4-(2-carboxybenzyloxy)phenylacetic acid (Olo-IM1) (yield: 174.6 g, 0.48 mol, 82.1percent; HPLC assay: 78.0percent). The crude Olo-IM1 (50.0 g, assay: 78.0percent, 0.14 mol) was recrystallized from acetonitrile/water (40 ml, 1/1). After filtration, the wet product washed successively with acetonitrile/water (98 ml, 1/1) and water (20 ml) to give slightly orange colored 4-(2-carboxybenzyloxy)phenylacetic acid (Olo-IM1) (yield: 35.27 g, 0.12 mol, 88.1percent; HPLC assay: 97.4percent; overall yield: 72.3percent).
Reference: [1] Patent: US2007/232814, 2007, A1, . Location in patent: Page/Page column 23
[2] Patent: US4282365, 1981, A,
[3] Patent: WO2011/128911, 2011, A2, . Location in patent: Page/Page column 20-21
  • 23
  • [ 156-38-7 ]
  • [ 34837-88-2 ]
Reference: [1] Patent: WO2013/19682, 2013, A1,
  • 24
  • [ 156-38-7 ]
  • [ 64-17-5 ]
  • [ 17138-28-2 ]
YieldReaction ConditionsOperation in experiment
100% for 1 h; Heating / reflux In a round-bottomed flask was placed 4-hydroxyphenyl acetic acid (10.0 g, 65.7 mmol), ethanol (120 ml) and cone. H2SO4 (1 ml). The mixture was heated at reflux for 1 hr and was then allowed to cool to room temperature. The mixture was carefully neutralized with aqueous NaHCC>3. Most of the ethanol was removed in vacuum. The aqueous phase was extracted with EtOAc, which was washed well with H2O and dried over Na2SC>4. Evaporation of the solvent gave the desired compound as an oil (11.8 g, 100percent). lB. NMR (400 MHz, CDCI3) 6 7.13 (d, 2H), 6.76 (d, 2H), 5.10 (s, 1H), 4.15 (q, 2H), 3.36 (s, 2H), 1.26 (t, 3H).
94% Heating / reflux A solution of 4-hydroxy phenyl acetic acid (4.5 g, 29.57 mmol) in benzene (60 mL) and ethanol (60 mL) was treated with concentrated sulfuric acid (2 mL) and heated to reflux overnight using a Dean-Stark water trap. The volatiles were evaporated in vacuo, the residue was diluted with water and extracted with diethyl ether (*2). The combined organic phase was washed with water (*1) and brine (*1), dried over anhydrous magnesium sulfate, filtered over a short bed of silica gel and evaporated in vacuo to afford the title product as an oil (5 g, 94percent). [0094] <1>H-NMR (300 MHz, CDCl3): [delta]1.23(t, J=6.7 Hz, 3H), 3.52(s, 2H), 4.14(q, J=6.7 Hz, 2H), 6.70(d, J=8.2 Hz, 2H), 7.06(d, J=8.5 Hz, 2H).
Reference: [1] Patent: WO2006/20916, 2006, A2, . Location in patent: Page/Page column 79
[2] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 22, p. 8092 - 8105
[3] Synthesis, 2003, # 16, p. 2479 - 2482
[4] Patent: US2003/191181, 2003, A1, . Location in patent: Page/Page column 10; 15
[5] Journal of Medicinal Chemistry, 1988, vol. 31, # 8, p. 1651 - 1656
[6] Tetrahedron Asymmetry, 1995, vol. 6, # 6, p. 1345 - 1356
[7] Synlett, 2000, # 1, p. 59 - 60
[8] Journal of Organic Chemistry, 2003, vol. 68, # 3, p. 1165 - 1167
[9] Tetrahedron Letters, 2005, vol. 46, # 35, p. 5945 - 5947
[10] Chemische Berichte, 1889, vol. 22, p. 2138
[11] Journal of Medicinal Chemistry, 1989, vol. 32, # 8, p. 1910 - 1913
[12] Journal of Medicinal Chemistry, 2002, vol. 45, # 1, p. 115 - 126
[13] Journal of the Chinese Chemical Society, 2008, vol. 55, # 1, p. 201 - 208
[14] Patent: EP1229034, 2002, A1, . Location in patent: Page 119-120
[15] Combinatorial Chemistry and High Throughput Screening, 2011, vol. 14, # 2, p. 132 - 137
[16] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 3, p. 618 - 631
[17] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 24, p. 7699 - 7708
[18] Tetrahedron Letters, 2015, vol. 56, # 8, p. 981 - 985
[19] Patent: WO2007/146768, 2007, A2, . Location in patent: Page/Page column 11
  • 25
  • [ 156-38-7 ]
  • [ 17138-28-2 ]
Reference: [1] Patent: EP355830, 1994, B1,
[2] Patent: US5338482, 1994, A,
[3] Patent: US4909957, 1990, A,
[4] Patent: US4829086, 1989, A,
  • 26
  • [ 156-38-7 ]
  • [ 144-55-8 ]
  • [ 17138-28-2 ]
Reference: [1] Patent: US5849930, 1998, A,
  • 27
  • [ 156-38-7 ]
  • [ 141-78-6 ]
  • [ 17138-28-2 ]
Reference: [1] Synthesis, 2000, # 12, p. 1671 - 1672
[2] Synthesis, 2003, # 16, p. 2479 - 2482
  • 28
  • [ 156-38-7 ]
  • [ 75-03-6 ]
  • [ 17138-28-2 ]
Reference: [1] Synthetic Communications, 1998, vol. 28, # 11, p. 2021 - 2026
  • 29
  • [ 156-38-7 ]
  • [ 105-58-8 ]
  • [ 17138-28-2 ]
Reference: [1] Organic Process Research and Development, 2009, vol. 13, # 4, p. 769 - 773
  • 30
  • [ 156-38-7 ]
  • [ 78-39-7 ]
  • [ 17138-28-2 ]
Reference: [1] Synthetic Communications, 2002, vol. 32, # 14, p. 2209 - 2213
  • 31
  • [ 156-38-7 ]
  • [ 34918-57-5 ]
Reference: [1] Yakugaku Zasshi, 1933, vol. 53, p. 557,563; dtsch. Ref. S. 92[2] Chem.Abstr., 1933, p. 4223
  • 32
  • [ 156-38-7 ]
  • [ 68641-16-7 ]
Reference: [1] European Journal of Organic Chemistry, 2006, # 6, p. 1489 - 1498
[2] Australian Journal of Chemistry, 1967, vol. 20, p. 1413 - 1428
  • 33
  • [ 156-38-7 ]
  • [ 10463-20-4 ]
YieldReaction ConditionsOperation in experiment
70% With nitric acid In acetic acid (a)
4-Hydroxy-3-nitrobenzene-acetic acid
Fuming nitric acid (1.36 mL) was slowly added to an ice cooled solution of 4-hydroxy-benzeneacetic acid (4.00 gm, 26.3 mmol) in acetic acid (25 mL).
The yellow solution was allowed to warm to room temperature over an hour as a brown precipitant formed.
The solid was filtered and recrystallized from ethyl acetate/hexanes as yellow needles (3.61 gm, 70percent yield): 1 H-NMR δ (CDCl3 -d4 DMSO, 4:1) 3.50 (2H, s), 7.04 (1H, d, J=9 Hz), 7.46 (1H, dd, J=9, 3 Hz), 7.94 (1H, d, J=3 Hz).
67.2% at 5℃; for 0.916667 h; 4-Hydroxyphenylacetic acid 1 (31 g; 203.7 mmol) was dissolved in acetic acid (186 mL) and cooled to 5 Celsius on ice bath. Nitric acid (62 mL of 50-70percent) was added dropwise to a solution of 4-hydroxyphenylacetic acid for 40 min. and the reaction mixture was held at that temperature for 15 min. The reaction mixture was added into 600 mL of water and filtered precipitate, washed with water, dried. MW C8H7NO5 197.14 g/mol; yield: 27 g (67.2percent); (0200) H-NMR (CD3OD): δ 8.00 (d, 1H); 7.53 (dd, 1H); 7.10 (d, 1H); 3.63 (s, 2H).
65% With nitric acid In (2S)-N-methyl-1-phenylpropan-2-amine hydrate; acetic acid In a first step, carried out according to Humel in Synth. Commun. 15, pages 1081-88 (1985), to a magnetically stirred solution of 100 g (0.65,mole) of 4-hydroxyphenyl acetic acid in 250 ml of glacial acetic acid was added dropwise a mixture of 40 ml of nitric acid (1.4 specific gravity) and 60 ml glacial acetic acid.
The glacial acetic acid was warmed to about 45° C. to completely dissolve the 4-hydroxyphenyl acetic acid.
Following addition of the nitric acid/acetic acid mixture, stirring of the resulting mixture was continued for one hour at 25° C. and then the flask was chilled in ice water for one hour.
The resulting crystals were washed with cold water and air-dried at room temperature, the reaction providing 65percent of the theoretical yield of 3-nitro 4-hydroxyphenyl acetic acid.
63.9% With nitric acid In water at 20℃; General procedure: An appropriate phenol compound 8a–13a (1 mmol) was mixed with 60percent HNO3 (4.8 mmol). Theresulting suspension was stirred at room temperature for 10 min for 8a and 9a, for 30 min for 10a, 12aand 13a, or overnight for 11a, leading eventually to an intensively dark red solution. HPLC analysisconfirmed the absence of starting material and the presence of 3 major products corresponding mostlikely to nitro derivatives resulting from nitration at the o- and p-positions of the hydroxy group fromthe m-substituted phenols 8a, 10a and 12a, but only one product from the p-substituted phenols 9a,11a and 13a. The crude nitrophenol 8b or 9b was diluted with water (20 mL) and applied onto aDowex 50W-X2 (200–400 mesh) column (1.5 cm × 6 cm, H+ form, equilibrated with water).The column was washed with water (100 mL) and then the product was eluted with 2 M HCl(20 mL/fraction). Fractions containing the target compound were combined and evaporated to drynessto give a yellow powder. After the nitration of phenols 10a, 12a and 13a, the reaction mixture (10b,12b and 13b) was diluted with H2O (20 mL) and extracted with ethyl acetate (2 × 100 mL). Thecombined organic extract was washed with water (2 × 50 mL), dried with Na2SO4 and evaporatedunder reduced pressure. The nitration of 11a afforded 11b as an orange powder in the reaction mixture.After the filtration, the powder was washed with water and dried under reduced pressure to give a darkred powder 11b.
62% at 10 - 15℃; for 2.5 h; (a) The solution of (4-hydroxyphenyl)acetic acid (4.65 g, 300 mmol) in glacial acetic acid (366 mL) was cooled to 10-15 °C, and nitric acid (100.5 mL, 65 w/wpercent) was added dropwise over a period of 1 hour. A precipitate was formed, and the mixture was stirred for 90 min at 10- 15 °C. Cold water (1100 mL) was added and stirred for 1 hour at 10-15 °C. The precipitate was filtered, washed with cold water (5x30 mL), and dried. 1-(4-Hydroxy-3-nitrophenyl)acetic acid was obtained (36.1 g, 62percent), mp: 145-150 °C.
62% With nitric acid; acetic acid In water at 10 - 15℃; for 2.5 h; The solution of (4-hydroxyphenyl)acetic acid (4.65 g, 300 mmol) in glacial acetic acid (366 mL) was cooled to 10-15°C, and nitric acid (100.5 mL, 65 w/w percent) was added dropwise over a period of 1 hour A precipitate was formed and the mixture was stirred for 90 min at 10-15°C. Cold water (1100 mL) was added and stirred for 1 hour at 10-15°C. The precipitate was filtered, washed with cold water (5 x 30 mL) and dried. 1-(4-hydroxy-3-nitrophenyl)acetic acid was obtained (36.1 g, 62percent); mp: 145-150°CΞ;
39% at 0℃; for 1 h; 2-(2-(3,5-dimethylisoxazol-4-yl)benzo[a) 2-(4-hydroxy-3-nitrophenyl)acetic acidTo a solution of 2-(4-hydroxyphenyl)acetic acid (10 g, 65.7 mmol) in AcOH (100 mL) at 0 °C was added concentrated HNO3 (5.3 mL, 118.4 mmol) dropwise and the reaction mixture was stirred for 1 h. The yellow solution was allowed to warm to rt. The resultant precipitate was collected by filtration and recrystallized from EtOAc/hexanes to provide the title compound (5.0 g, 39percent) as a yellow solid. H NMR (400 MHz, DMSO-d6) δ ppm 12.44 (br s, 1H), 10.87 (s, 1H), 7.80 (d, 1H), 7.44 (dd, 1H), 7.08 (d, 1H), 3.59 (s, 2H).

Reference: [1] Synthetic Communications, 1985, vol. 15, # 12, p. 1075 - 1080
[2] Patent: US5229510, 1993, A,
[3] Journal of Medicinal Chemistry, 1987, vol. 30, # 7, p. 1166 - 1176
[4] Patent: US9995679, 2018, B2, . Location in patent: Page/Page column 52
[5] Patent: US5852191, 1998, A,
[6] Molecules, 2014, vol. 19, # 6, p. 8039 - 8050
[7] Patent: WO2015/110848, 2015, A1, . Location in patent: Page/Page column 16
[8] Patent: US2017/2020, 2017, A1, . Location in patent: Paragraph 0065
[9] Canadian Journal of Chemistry, 2001, vol. 79, # 5-6, p. 792 - 794
[10] Patent: WO2013/19682, 2013, A1, . Location in patent: Page/Page column 103
[11] Bioorg. Med. Chem. Lett., 1997, vol. 7, # 22, p. 2913 - 2918
[12] Bioscience, Biotechnology and Biochemistry, 1998, vol. 62, # 3, p. 448 - 452
[13] Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, 1958, vol. 312, p. 168,182
[14] Bioscience, biotechnology, and biochemistry, 2000, vol. 64, # 8, p. 1751 - 1753
[15] Patent: US2003/158177, 2003, A1,
[16] Patent: US4593106, 1986, A,
[17] Patent: US4554284, 1985, A,
[18] Patent: WO2010/75469, 2010, A1, . Location in patent: Page/Page column 120
[19] Patent: US2011/9628, 2011, A1, . Location in patent: Page/Page column 41-42
[20] Patent: US2013/244891, 2013, A1, . Location in patent: Page/Page column
[21] Patent: WO2013/131408, 2013, A1, . Location in patent: Page/Page column 90
  • 34
  • [ 156-38-7 ]
  • [ 102-32-9 ]
  • [ 10463-20-4 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 38, p. 6933 - 6937
  • 35
  • [ 156-38-7 ]
  • [ 38692-80-7 ]
Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1989, vol. 322, p. 483 - 487
[2] Yakugaku Zasshi, 1933, vol. 53, p. 557,563; dtsch. Ref. S. 92[3] Chem.Abstr., 1933, p. 4223
  • 36
  • [ 156-38-7 ]
  • [ 17194-82-0 ]
  • [ 29121-26-4 ]
  • [ 24744-58-9 ]
  • [ 38692-80-7 ]
Reference: [1] Helvetica Chimica Acta, 1984, vol. 67, # 6, p. 1484 - 1492
  • 37
  • [ 156-38-7 ]
  • [ 17194-96-6 ]
  • [ 29121-26-4 ]
  • [ 24744-58-9 ]
  • [ 38692-80-7 ]
Reference: [1] Helvetica Chimica Acta, 1984, vol. 67, # 6, p. 1484 - 1492
  • 38
  • [ 156-38-7 ]
  • [ 96524-70-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 21, p. 5488 - 5492
Same Skeleton Products
Historical Records